C16TR not checked

Insmed Incorporated

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Administered as inhalation using a Philips Micro device inhaler.”In the company’s words, NCT06193031 on ClinicalTrials.gov
Main trialPhase 1
“The primary purpose of this study is to determine the safety and tolerability of escalating doses of C16TR for inhalation in healthy participants.”In the company’s words, NCT06193031 on ClinicalTrials.gov
Other names
Hexadecyl-treprostinil
Copy of
Tyvaso (United Therap)Tested side by side with the original in NCT06193031

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1Completed 18 Dec 2015 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow C16TR

Following is part of Solo: you see every change to C16TR the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in